Literature DB >> 19357632

HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006.

.   

Abstract

Since the late 1980s, incidence of human immunodeficiency virus infection (HIV) has declined 80% among injecting-drug users (IDUs) in the United States; in 2006, an estimated 6,600 (12%) of new HIV infections occurred among IDUs. To assess HIV-associated behaviors among IDUs at risk for HIV infection, CDC analyzed data from the National HIV Behavioral Surveillance System (NHBS) collected during May 2005--February 2006 (the most recent data available). The results of that analysis indicated that, during that period, 31.8% of participating IDUs reported sharing syringes, and 62.6% had unprotected vaginal sex; 71.5% had been tested for HIV, and 27.4% had participated in an HIV behavioral intervention. These data can help guide local, state, and national prevention services tailored to IDUs at risk for HIV infection and other bloodborne or sexually transmitted infections.

Entities:  

Mesh:

Year:  2009        PMID: 19357632

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  28 in total

1.  Assessing respondent-driven sampling.

Authors:  Sharad Goel; Matthew J Salganik
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

2.  Risk Behaviors Among Suburban Women who Use Methamphetamine: Social Harms and Social Solutions.

Authors:  Aukje Lamonica; Miriam Boeri
Journal:  J Appl Soc Sci (Boulder)       Date:  2015-09-01

3.  Changes in blood-borne infection risk among injection drug users.

Authors:  Shruti H Mehta; Jacqueline Astemborski; Gregory D Kirk; Steffanie A Strathdee; Kenrad E Nelson; David Vlahov; David L Thomas
Journal:  J Infect Dis       Date:  2011-01-31       Impact factor: 5.226

4.  Substance abuse treatment as HIV prevention: more questions than answers.

Authors:  Lawrence S Brown; Steven Kritz; Edmund J Bini; Ben Louie; Jim Robinson; Donald Alderson; John Rotrosen
Journal:  J Natl Med Assoc       Date:  2010-12       Impact factor: 1.798

5.  The influence of the perceived consequences of refusing to share injection equipment among injection drug users: balancing competing risks.

Authors:  Karla D Wagner; Stephen E Lankenau; Lawrence A Palinkas; Jean L Richardson; Chih-Ping Chou; Jennifer B Unger
Journal:  Addict Behav       Date:  2011-03-25       Impact factor: 3.913

6.  Sexual partnering and HIV risk among black men who have sex with men: New York City.

Authors:  Hong-Van Tieu; Christopher Murrill; Guozhen Xu; Beryl A Koblin
Journal:  J Urban Health       Date:  2009-12-01       Impact factor: 3.671

7.  Evaluating consistency in repeat surveys of injection drug users recruited by respondent-driven sampling in the Seattle area: results from the NHBS-IDU1 and NHBS-IDU2 surveys.

Authors:  Richard D Burt; Hanne Thiede
Journal:  Ann Epidemiol       Date:  2012-03-14       Impact factor: 3.797

8.  Overlooked Threats to Respondent Driven Sampling Estimators: Peer Recruitment Reality, Degree Measures, and Random Selection Assumption.

Authors:  Jianghong Li; Thomas W Valente; Hee-Sung Shin; Margaret Weeks; Alexei Zelenev; Gayatri Moothi; Heather Mosher; Robert Heimer; Eduardo Robles; Greg Palmer; Chinekwu Obidoa
Journal:  AIDS Behav       Date:  2018-07

9.  Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia.

Authors:  Chaturaka Rodrigo; Auda A Eltahla; Rowena A Bull; Jason Grebely; Gregory J Dore; Tanya Applegate; Kimberly Page; Julie Bruneau; Meghan D Morris; Andrea L Cox; William Osburn; Arthur Y Kim; Janke Schinkel; Naglaa H Shoukry; Georg M Lauer; Lisa Maher; Margaret Hellard; Maria Prins; Chris Estes; Homie Razavi; Andrew R Lloyd; Fabio Luciani
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 5.226

10.  Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.

Authors:  Steffanie A Strathdee; Jamila K Stockman
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.